GoAI
Get started
Ardent Health Inc. logo

Ardent Health Inc.

ARDT

NYSEHealthcareMedical - Care Facilities

Open in GoAI

Previous close

$10.99

+$0.51 · +4.87%

Aug 21, 4:00 PM ET

Pre-market

$10.99

$0.00 · 0.00%

Aug 24, 6:03 AM ET

ARDT company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

82

Deep Value

Momentum

46

Neutral

Sentiment

47

Mixed

Risk resilience

41

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Dave Caspers
Listed since
Jul 18, 2024
Employees
22,350

Market position

Day range

Current $10.99

52-week range

Current $10.99

Open
$10.66
Previous close
$10.48
Volume
175.76K
0.35× average
Average volume
504.76K
Average daily volume
Market cap
1.58B USD
Beta
0.7
Market reference 1
50-day average
$10.339
+6.30% above average
200-day average
$9.6082
+14.38% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.8B USD
P/E (TTM)
19.98×
P/B (TTM)
1.15×
P/S (TTM)
0.25×
EV / EBITDA
5.63×
Earnings yield
10.93%
Free cash flow yield
20.81%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
29.96%
Operating margin
7.54%
Net margin
1.22%
Return on equity
8.05%
Return on assets
2.57%
Return on invested capital
6.13%

Financial health

Debt / equity
1.68×
Current ratio
1.97×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends107%69%30%-9%Gross margin, FY2021: 80.96%Gross margin, FY2022: 81.38%Gross margin, FY2023: 97.40%Gross margin, FY2024: 82.68%Gross margin, FY2025: 97.54%Operating margin, FY2021: 8.96%Operating margin, FY2022: 4.23%Operating margin, FY2023: 4.24%Operating margin, FY2024: 6.80%Operating margin, FY2025: 5.15%Net margin, FY2021: 3.17%Net margin, FY2022: 3.68%Net margin, FY2023: 0.93%Net margin, FY2024: 3.53%Net margin, FY2025: 2.15%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 80.96%. Gross margin FY2022 81.38%. Gross margin FY2023 97.40%. Gross margin FY2024 82.68%. Gross margin FY2025 97.54%. Operating margin FY2021 8.96%. Operating margin FY2022 4.23%. Operating margin FY2023 4.24%. Operating margin FY2024 6.80%. Operating margin FY2025 5.15%. Net margin FY2021 3.17%. Net margin FY2022 3.68%. Net margin FY2023 0.93%. Net margin FY2024 3.53%. Net margin FY2025 2.15%.

Income trends

Revenue

6.32B USD+6.01%

Operating income

325.58M USD-19.76%

Net income

135.81M USD-35.43%
Income trends across reported periods6.95B USD4.44B USD1.93B USD−577.11M USDRevenue, FY2021: 4.87B USDRevenue, FY2022: 5.13B USDRevenue, FY2023: 5.41B USDRevenue, FY2024: 5.97B USDRevenue, FY2025: 6.32B USDOperating income, FY2021: 436.56M USDOperating income, FY2022: 217.03M USDOperating income, FY2023: 229.5M USDOperating income, FY2024: 405.76M USDOperating income, FY2025: 325.58M USDNet income, FY2021: 154.26M USDNet income, FY2022: 188.91M USDNet income, FY2023: 50.29M USDNet income, FY2024: 210.34M USDNet income, FY2025: 135.81M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 4.87B USD. Revenue FY2022 5.13B USD. Revenue FY2023 5.41B USD. Revenue FY2024 5.97B USD. Revenue FY2025 6.32B USD. Operating income FY2021 436.56M USD. Operating income FY2022 217.03M USD. Operating income FY2023 229.5M USD. Operating income FY2024 405.76M USD. Operating income FY2025 325.58M USD. Net income FY2021 154.26M USD. Net income FY2022 188.91M USD. Net income FY2023 50.29M USD. Net income FY2024 210.34M USD. Net income FY2025 135.81M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue6.32B USD5.97B USD5.41B USD5.13B USD4.87B USD
Cost of goods sold155.7M USD1.03B USD140.84M USD955.17M USD927.33M USD
Gross profit6.17B USD4.93B USD5.27B USD4.17B USD3.94B USD
Selling, general, and administrative1.19B USD3.88B USD3.62B USD3.37B USD3.13B USD
Operating expenses5.84B USD4.53B USD5.04B USD3.96B USD3.51B USD
Interest expense55.2M USD65.58M USD65.43M USD82.05M USD93.83M USD
Depreciation and amortization155.7M USD146.29M USD140.84M USD138.17M USD137.2M USD
Operating income325.58M USD405.76M USD229.5M USD217.03M USD436.56M USD
Net income135.81M USD210.34M USD50.29M USD188.91M USD154.26M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
67%
6 beats, 3 misses, 0 met estimates
Average EPS surprise
+19.96%
9 comparable reports
Latest EPS result
0.12
Estimate 0.18 · Miss by 33.96%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.870.610.360.1Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26MissQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 26, 2025: actual 0.81, estimate 0.5, surprise +62.00%, Beat. Q2 2025, reported May 6, 2025: actual 0.29, estimate 0.21, surprise +38.10%, Beat. Q3 2025, reported Aug 5, 2025: actual 0.52, estimate 0.3, surprise +73.33%, Beat. Q4 2025, reported Nov 12, 2025: actual 0.52, estimate 0.424, surprise +22.64%, Beat. Q1 2026, reported Mar 4, 2026: actual 0.32, estimate 0.348, surprise -8.05%, Miss. Q2 2026, reported May 5, 2026: actual 0.28, estimate 0.18, surprise +55.56%, Beat. Q3 2026, reported Aug 4, 2026: actual 0.12, estimate 0.182, surprise -33.96%, Miss. Q4 2026, reported Nov 11, 2026: actual —, estimate 0.23, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.71B1.62B1.52B1.43BQ1 '25BeatQ2 '25MissQ3 '25BeatQ4 '25BeatQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 26, 2025: actual 1.61B USD, estimate 1.5B USD, surprise +7.26%, Beat. Q2 2025, reported May 6, 2025: actual 1.5B USD, estimate 1.5B USD, surprise -0.03%, Miss. Q3 2025, reported Aug 5, 2025: actual 1.65B USD, estimate 1.63B USD, surprise +0.70%, Beat. Q4 2025, reported Nov 12, 2025: actual 1.58B USD, estimate 1.55B USD, surprise +1.79%, Beat. Q1 2026, reported Mar 4, 2026: actual 1.61B USD, estimate 1.63B USD, surprise -1.60%, Miss. Q2 2026, reported May 5, 2026: actual 1.6B USD, estimate 1.58B USD, surprise +1.53%, Beat. Q3 2026, reported Aug 4, 2026: actual 1.62B USD, estimate 1.59B USD, surprise +2.05%, Beat. Q4 2026, reported Nov 11, 2026: actual —, estimate 1.6B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Recent analyst actions

12 institutions

ARDT peers

Eli Lilly and Company logo

LLY

Eli Lilly and Company

$1,254.77

+0.83%

Johnson & Johnson logo

JNJ

Johnson & Johnson

$270.24

+1.07%

AbbVie Inc. logo

ABBV

AbbVie Inc.

$265.01

+1.21%

Merck & Co., Inc. logo

MRK

Merck & Co., Inc.

$152.55

+2.39%

UnitedHealth Group Incorporated logo

UNH

UnitedHealth Group Incorporated

$390.11

+1.37%

Novartis AG logo

NVS

Novartis AG

$158.86

+1.68%

ETFs holding ARDT

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
7.06M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
6.65M
Weight
0.01%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
EA Bridgeway Omni Small-Cap Value ETF logoEA Bridgeway Omni Small-Cap Value ETFBSVO
Market value
6.06M
Weight
0.25%
AUM
1.71B USD
Expense ratio
0.47%
Price / 1D
$29.62+0.85%
Avantis U.S. Small Cap Value ETF logoAvantis U.S. Small Cap Value ETFAVUV
Market value
5.04M
Weight
0.02%
AUM
31.27B USD
Expense ratio
0.25%
Price / 1D
$126.45+0.66%
First Trust Small Cap Core AlphaDEX Fund logoFirst Trust Small Cap Core AlphaDEX FundFYX
Market value
4.69M
Weight
0.34%
AUM
1.4B USD
Expense ratio
0.58%
Price / 1D
$143.78+0.66%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
2.98M
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares Russell 2000 Value ETF logoiShares Russell 2000 Value ETFIWN
Market value
2.4M
Weight
0.02%
AUM
14.66B USD
Expense ratio
0.24%
Price / 1D
$224.81+0.45%
WisdomTree U.S. SmallCap Fund logoWisdomTree U.S. SmallCap FundEES
Market value
1.78M
Weight
0.26%
AUM
739.61M USD
Expense ratio
0.38%
Price / 1D
$68.46+0.63%

Continue in GoAI

Research ARDT

research.disclaimer